CRT 2018 Late-Breaking Trials

Cardiovasc Revasc Med. 2018 Sep;19(6S):2-6. doi: 10.1016/j.carrev.2018.08.009. Epub 2018 Aug 14.

Authors

Micaela Iantorno¹, Kyle D Buchanan¹, Deepakraj Gajanana¹, Saina Attaran¹, Toby Rogers¹, Ron Waksman²

Affiliations

¹ Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
² Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America. Electronic address: ron.waksman@medstar.net.

PMID: 30322498
DOI: 10.1016/j.carrev.2018.08.009

No abstract available

Publication types

Congress

MeSH terms

Cardiovascular Diseases / mortality
Cardiovascular Diseases / physiopathology
Cardiovascular Diseases / surgery*
Clinical Trials as Topic*
Coronary Artery Disease / mortality
Coronary Artery Disease / physiopathology
Coronary Artery Disease / surgery*
Drug-Eluting Stents
Endovascular Procedures* / adverse effects
Endovascular Procedures* / instrumentation
Endovascular Procedures* / mortality
Humans
Percutaneous Coronary Intervention* / adverse effects
Percutaneous Coronary Intervention* / instrumentation
Percutaneous Coronary Intervention* / methods
Risk Assessment
Risk Factors
Transcatheter Aortic Valve Replacement* / adverse effects
Transcatheter Aortic Valve Replacement* / mortality
Treatment Outcome